LEADER 05278nam 2200601 450 001 9910132337303321 005 20230807212136.0 010 $a1-118-50449-6 010 $a1-118-50451-8 035 $a(CKB)3710000000272526 035 $a(EBL)1832719 035 $a(OCoLC)894792339 035 $a(MiAaPQ)EBC1832719 035 $a(Au-PeEL)EBL1832719 035 $a(CaPaEBR)ebr10964413 035 $a(EXLCZ)993710000000272526 100 $a20140505d2015 uy| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aUrgent interventional therapies /$fedited by Nicholas Kipshidze [and four others] ; assistant editor, Cathy Kennedy ; foreword by Martin B. Leon 210 1$aChichester, West Sussex, United Kingdom :$cJohn Wiley & Sons Limited,$d2015. 215 $a1 online resource (595 p.) 300 $aDescription based upon print version of record. 311 $a0-470-67202-1 320 $aIncludes bibliographical references and index. 327 $aUrgent Interventional Therapies; Copyright; Contents; List of Contributors; Foreword; Preface; List of Abbreviations; About the Companion Website; Part 1 Cardiac Interventions; Section I: Acute Coronary Syndrome; Chapter 1 Acute Coronary Syndrome: Guidelines and Definitions; Introduction; Definitions; Pathophysiology; Therapeutic strategies; Other considerations; References; Chapter 2 Cardiac Biomarkers in Acute Cardiac Care; Introduction; Markers of endothelial dysfunction; Biomarkers of vascular inflammation; Biomarkers of myocardial ischemia; Biomarkers of plaque destabilization 327 $aBiomarkers of plaque rupture Biomarkers of myocardial injury; Biomarkers of myocardial stretch or dysfunction; Summary; References; Chapter 3 Diagnosis of Vulnerable Plaque; Introduction; Coronary angiography; Intravascular ultrasound; Coronary angioscopy; Near-infrared spectroscopy; Optical coherence tomography; Intravascular thermography; Interventional treatment of vulnerable plaques; Conclusion; Summary; References; Chapter 4 Management of Thrombotic Disorders: Heparin to Newer Anticoagulants; Introduction and overview; Low molecular weight heparins; Ultra-low molecular weight heparins 327 $aAntithrombin agents Factor Xa inhibitors; Generic antithrombotic drugs; Newer oral anticoagulants versus heparins; Some unanswered questions regarding the new oral anticoagulants; Summary; Future perspectives; References; Chapter 5 Newer Antiplatelet Agents for Interventional Indications; Introduction; Clopidogrel; Prasugrel; Ticagrelor; Conclusion; References; Chapter 6 Genetic Considerations of Antiplatelet Therapy; Introduction; General considerations; Specific genetic considerations; Therapeutic strategies; Practical recommendations; References 327 $aChapter 7 Anticoagulant Management of Heparin-Compromised Patients Introduction; Heparin; Anticoagulant alternatives to heparin; Summary; References; Chapter 8 Management of Bleeding in Urgent Interventions; Introduction; Incidence of bleeding; Risks associated with increased bleeding; Long-term outcomes; Mechanical and other contributors to bleeding; Measures to reduce the incidence of bleeding; Treatment of bleeding; New potential agents for the reversal of anticoagulation; References; Chapter 9 Role of Newer Anti-Xa and Anti-IIa Agents for Interventions; Introduction 327 $aPercutaneous coronary intervention New anti-IIa and anti-Xa agents; New anticoagulants for cardiac interventional procedures; Conclusion; Summary; References; Chapter 10 Treatment of NSTEMI Patients; Introduction; Presentation and diagnosis; Antiplatelet therapies; Anticoagulation strategies; Invasive versus medical therapy; Conclusion; References; Chapter 11 Treatment of Patients with STEMI; Introduction; Indication; Literature review; Invasive treatment center; Technique of primary PCI; Summary; References 327 $aChapter 12 Mechanical Removal of Thrombus from Culprit Lesions: Current Devices and Future Developments 330 $aIllustrating the differences between urgent interventions and interventions performed to manage chronic conditions the authors present the chapters in a consistent template for ease of use covering; background, indications, evidence review, device description, procedural techniques, follow-up care, and complications. Shows the differences between interventions performed to manage chronic conditions and interventions that are truly urgent Chapters follow a consistent structure from background through indications, evidence review, device description, procedural techniques to follow-up care and 606 $aCritical care medicine 606 $aCritical care$vMethods 615 0$aCritical care medicine. 615 0$aCritical care 676 $a616.02/8 702 $aKipshidze$b Nicholas 702 $aFareed$b Jawed 702 $aRosen$b Robert J$g(Robert Jay),$f1951- 702 $aDangas$b George D. 702 $aSerruys$b P. W. 702 $aKennedy$b Catherine 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910132337303321 996 $aUrgent interventional therapies$92063049 997 $aUNINA